Knowles Corporation (NYSE: KN) has announced the appointment of Laura Angelini as an independent director to the company's board of directors. Ms. Angelini brings with her 30 years of experience in the medical device and healthcare industry, having most recently served as the general manager of the renal care global business unit at Baxter International Inc. from 2016 to 2021. She has also held various roles at Johnson & Johnson.
Knowles Corporation, a leading global supplier of high-performance electronics for demanding applications, has highlighted the extensive executive, global, and strategic marketing experience that Ms. Angelini brings to the table. The company's Chairman of the Board, Don MacLeod, expressed excitement about welcoming her to the board and emphasized the potential benefits of her insights into the healthcare and medical markets as Knowles continues its strategic transformation.
In addition to joining the board of directors, Ms. Angelini will also serve as a member of the compensation committee. Knowles Corporation, founded in 1946 and headquartered in Itasca, Illinois, is a global organization with employees in 11 countries. The company is focused on delivering innovative solutions across multiple applications, with a particular emphasis on diversifying its revenue and increasing exposure to high-growth markets. Today the company's shares have moved 1.1% to a price of $19.79. For more information, read the company's full 8-K submission here.
